183 related articles for article (PubMed ID: 9192978)
1. Abnormal expression of CCND1 and RB1 in resection margin epithelia of lung cancer patients.
Betticher DC; Heighway J; Thatcher N; Hasleton PS
Br J Cancer; 1997; 75(12):1761-8. PubMed ID: 9192978
[TBL] [Abstract][Full Text] [Related]
2. G1 control gene status is frequently altered in resectable non-small cell lung cancer.
Betticher DC; White GR; Vonlanthen S; Liu X; Kappeler A; Altermatt HJ; Thatcher N; Heighway J
Int J Cancer; 1997 Oct; 74(5):556-62. PubMed ID: 9355981
[TBL] [Abstract][Full Text] [Related]
3. Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity.
Jares P; Campo E; Pinyol M; Bosch F; Miquel R; Fernandez PL; Sanchez-Beato M; Soler F; Perez-Losada A; Nayach I; Mallofré C; Piris MA; Montserrat E; Cardesa A
Am J Pathol; 1996 May; 148(5):1591-600. PubMed ID: 8623927
[TBL] [Abstract][Full Text] [Related]
4. p21 is associated with cyclin D1, p16INK4a and pRb expression in resectable non-small cell lung cancer.
Vonlanthen S; Heighway J; Kappeler A; Altermatt HJ; Borner MM; Betticher DC
Int J Oncol; 2000 May; 16(5):951-7. PubMed ID: 10762631
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of NCAM, p53 and cyclin D1 in resected non-small cell lung cancer.
Kwa HB; Michalides RJ; Dijkman JH; Mooi WJ
Lung Cancer; 1996 Jun; 14(2-3):207-17. PubMed ID: 8794404
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1, p16 and retinoblastoma gene product expression as a predictor for prognosis in non-small cell lung cancer at stages I and II.
Jin M; Inoue S; Umemura T; Moriya J; Arakawa M; Nagashima K; Kato H
Lung Cancer; 2001 Nov; 34(2):207-18. PubMed ID: 11679179
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 and retinoblastoma gene expression in human breast carcinoma: correlation with tumour proliferation and oestrogen receptor status.
Jares P; Rey MJ; Fernández PL; Campo E; Nadal A; Muñoz M; Mallofré C; Muntané J; Nayach I; Estapé J; Cardesa A
J Pathol; 1997 Jun; 182(2):160-6. PubMed ID: 9274525
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer.
Betticher DC; Heighway J; Hasleton PS; Altermatt HJ; Ryder WD; Cerny T; Thatcher N
Br J Cancer; 1996 Feb; 73(3):294-300. PubMed ID: 8562333
[TBL] [Abstract][Full Text] [Related]
9. Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein.
Nielsen NH; Emdin SO; Cajander J; Landberg G
Oncogene; 1997 Jan; 14(3):295-304. PubMed ID: 9018115
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of p21waf1, cyclin D1 and retinoblastoma expression detected by immunohistochemistry in non-small cell lung cancer.
Saitoh G; Sugio K; Ishida T; Sugimachi K
Oncol Rep; 2001; 8(4):737-43. PubMed ID: 11410775
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of cyclin D1 overexpression in correlation with pRb and p53 status in non-small cell lung cancer (NSCLC).
Dworakowska D; Jassem E; Jassem J; Boltze C; Wiedorn KH; Dworakowski R; Skokowski J; Jaśkiewicz K; Czestochowska E
J Cancer Res Clin Oncol; 2005 Jul; 131(7):479-85. PubMed ID: 15809880
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D1 expression in non-small-cell lung cancers: its association with altered p53 expression, cell proliferation and clinical outcome.
Mishina T; Dosaka-Akita H; Kinoshita I; Hommura F; Morikawa T; Katoh H; Kawakami Y
Br J Cancer; 1999 Jun; 80(8):1289-95. PubMed ID: 10376986
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of cyclin D1 and retinoblastoma expression in combination with p53 abnormalities in primary, resected non-small cell lung cancers.
Nishio M; Koshikawa T; Yatabe Y; Kuroishi T; Suyama M; Nagatake M; Sugiura T; Ariyoshi Y; Mitsudomi T; Takahashi T
Clin Cancer Res; 1997 Jul; 3(7):1051-8. PubMed ID: 9815783
[TBL] [Abstract][Full Text] [Related]
14. Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines.
Huang L; Lang D; Geradts J; Obara T; Klein-Szanto AJ; Lynch HT; Ruggeri BA
Mol Carcinog; 1996 Feb; 15(2):85-95. PubMed ID: 8599583
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D1 overexpression vs. retinoblastoma inactivation: implications for growth control evasion in non-small cell and small cell lung cancer.
Schauer IE; Siriwardana S; Langan TA; Sclafani RA
Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7827-31. PubMed ID: 8052667
[TBL] [Abstract][Full Text] [Related]
16. Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer.
Jiang W; Zhang YJ; Kahn SM; Hollstein MC; Santella RM; Lu SH; Harris CC; Montesano R; Weinstein IB
Proc Natl Acad Sci U S A; 1993 Oct; 90(19):9026-30. PubMed ID: 8415648
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of cyclins D1 and E is frequent in bronchial preneoplasia and precedes squamous cell carcinoma development.
Lonardo F; Rusch V; Langenfeld J; Dmitrovsky E; Klimstra DS
Cancer Res; 1999 May; 59(10):2470-6. PubMed ID: 10344760
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of cyclin D1 correlates with early recurrence in superficial bladder cancers.
Shin KY; Kong G; Kim WS; Lee TY; Woo YN; Lee JD
Br J Cancer; 1997; 75(12):1788-92. PubMed ID: 9192983
[TBL] [Abstract][Full Text] [Related]
19. Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas.
Maelandsmo GM; Flørenes VA; Hovig E; Oyjord T; Engebraaten O; Holm R; Børresen AL; Fodstad O
Br J Cancer; 1996 Apr; 73(8):909-16. PubMed ID: 8611425
[TBL] [Abstract][Full Text] [Related]
20. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]